|
Market Closed -
NYSE
00:00:00 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1.080 USD | -1.82% |
|
-0.92% | -35.33% |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 08-07 | Lineage Cell Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 273M 236M 222M 202M 380M 25.93B 382M 2.63B 1.02B 13.18B 1.03B 1B 43.76B | P/E 2026 * |
-16.1x | P/E 2027 * | -10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 273M 236M 222M 202M 380M 25.93B 382M 2.63B 1.02B 13.18B 1.03B 1B 43.76B | EV / Sales 2026 * |
18x | EV / Sales 2027 * | 16.2x |
| Free-Float |
95.14% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Lineage Cell Therapeutics, Inc.
| 1 day | -1.82% | ||
| 1 week | -0.92% | ||
| Current month | -1.82% | ||
| 3 months | -18.80% | ||
| 6 months | -43.75% | ||
| Current year | -35.33% |
| 1 week | 1.08 |  | 1.18 |
| 1 month | 1.04 | | 1.18 |
| Current year | 1 | | 1.98 |
| 1 year | 1 | | 2.09 |
| 3 years | 0.37 | | 2.09 |
| 5 years | 0.37 | | 2.8 |
| 10 years | 0.37 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 54 | 17/09/2018 |
Jill Howe
DFI | Director of Finance/CFO | 50 | 14/11/2022 |
Priyantha Herath
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 60 | 01/07/2009 |
Deborah Andrews
BRD | Director/Board Member | 68 | 11/04/2014 |
Michael Mulroy
CHM | Chairman | 60 | 27/04/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/07/26 | Free | Director | 125,000 | 0.0501% | ||
| 01/07/26 | Broadwood Capital, Inc.
| Free | Company | 125,000 | 0.0501% | |
| 01/07/26 | Free | Director | 125,000 | 0.0501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.82% | -0.92% | -7.69% | -18.18% | 278M | |
| +0.21% | -1.70% | +1.90% | +18.18% | 49.81B | |
| +2.09% | -0.81% | +452.73% | +517.81% | 44.06B | |
| -1.09% | -0.73% | +35.40% | +16.04% | 42.99B | |
| -0.26% | -3.58% | +17.19% | +72.80% | 40.88B | |
| -0.48% | -3.09% | +17.78% | +49.80% | 33.11B | |
| -1.81% | -5.94% | +22.65% | +115.79% | 16.58B | |
| -1.06% | +3.29% | - | - | 17.27B | |
| -1.35% | -2.32% | +10.40% | +25.90% | 14.63B | |
| -2.05% | -5.44% | +72.89% | +36.51% | 13.76B | |
| Average | -0.91% | -1.38% | +69.25% | +92.74% | 27.34B | |
| Weighted average by Cap. | -0.48% | -1.79% | +95.21% | +124.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.19M 13.11M 12.33M 11.24M 21.11M 1.44B 21.26M 146M 56.74M 733M 57.04M 55.8M 2.43B | 16.83M 14.52M 13.66M 12.46M 23.39M 1.6B 23.56M 162M 62.87M 813M 63.2M 61.83M 2.7B |
| Net income | -22.64M -19.53M -18.37M -16.75M -31.46M -2.15B -31.68M -218M -84.55M -1.09B -85M -83.15M -3.63B | -34.44M -29.71M -27.95M -25.48M -47.86M -3.27B -48.19M -331M -129M -1.66B -129M -126M -5.52B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 01/09/26 | $1.080 | -1.82% | 902,600 |
| 31/08/26 | $1.100 | -0.90% | 583,452 |
| 28/08/26 | $1.110 | -4.31% | 587,284 |
| 27/08/26 | $1.160 | +3.57% | 970,055 |
| 26/08/26 | $1.120 | -0.88% | 807,687 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LCTX Stock
Select your edition
All financial news and data tailored to specific country editions
